| Literature DB >> 34771102 |
Niamat Khan1,2, Sidra Shahid1, Abdul R Asif1.
Abstract
Chromatin is a dynamic structure comprising of DNA and proteins. Its unique nature not only help to pack the DNA tightly within the cell but also is pivotal in regulating gene expression DNA replication. Furthermore it also protects the DNA from being damaged. Various proteins are involved in making a specific complex within a chromatin and the knowledge about these interacting partners is helpful to enhance our understanding about the pathophysiology of various chromatin associated diseases. Moreover, it could also help us to identify new drug targets and design more effective remedies. Due to the existence of chromatin in different forms under various physiological conditions it is hard to develop a single strategy to study chromatin associated proteins under all conditions. In our current review, we tried to provide an overview and comparative analysis of the strategies currently adopted to capture the DNA bounded protein complexes and their mass spectrometric identification and quantification. Precise information about the protein partners and their function in the DNA-protein complexes is crucial to design new and more effective therapeutic molecules against chromatin associated diseases.Entities:
Keywords: PICh; QTIP; centromere; chromatin; chromatin immunoprecipitation (ChIP); euchromatin; heterochromatin; iTRAQ; interphase; proteome; telomere
Mesh:
Substances:
Year: 2021 PMID: 34771102 PMCID: PMC8588255 DOI: 10.3390/molecules26216694
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Approaches to identify specific chromatin locus associated proteome.
| Technique | Material | Chromatin Shearing/Isolation | Identified Proteins | Ref. | ||||
|---|---|---|---|---|---|---|---|---|
| Cells | Fixation | Lysis Buffer | Chromosomes (Region) | Shearing Approach | Bait | |||
| iTRAQ-ChEP | 293F Cells | NA/Nonidet P-40 | 10 mM KCl, 10 mM HEPES pH 7.5, 1 mM DTT, 1 mM MgCl2, 0.34 M sucrose, 0.1% triton X-100, and protease inhibitors | Chromatin | MNase, 5–10 U, 37 °C, 10 min | 481 | [ | |
| ChroP | HeLa S3 Cells | 0.75% FH | 60 mM KCl, 15 mM NaCl, 15 mM HEPES, 10% sucrose, 1 mM DTT, 0.5 mM EGTA pH 8.0, 0.5 mM PMSF, 0.5% Triton, 5 μg/mL Aprotinin, 5 μg/mL Leupeptin.5 mM NAF, 5 mM Na3VO4, 5 mM NaButyrate, 5 μg/mL Pepstatin A. | (Hetero and Euo) Chromatin | MNase: 0.005 U/L, 37 °C, 60 min | Anti- H3K9me3 | 837 | [ |
| Anti- H3K4me3 | 381 | |||||||
| QTIP | HeLa Cells | 1% FH | 50 mM Tris-HCl pH 8.0, 10 mM EDTA-NaOH pH 8.0, 1% SDS, EDTA-free protease inhibitors | Telomere | Sonication Bioruptor: | Anti-TRF1, and Anti-TRF2 | 324 | [ |
| PICh | HeLa S3 Cells | 3% FH | LBJD: 10 mM, HEPES-NaOH, pH 7.9; 100 mM NaCl; 2 mM EDTA, pH 8; 1 mM EGTA, pH 8; 0.2% SDS; 0.1% Sarkosyl, protease inhibitors | Telomere | Sonication: Power setting 7 (36–45 Watts), 15 s pulse on, | nucleic acid probe | 210 (Hela)190 (W138-VA13) | [ |
| 3% FH | 100 mM NaCl,10 mM Potassium Phosphate pH 7.0, 12% Hexylene glycol, 0.1% mercaptoethanol | Centromere | MNase: 0.15 U/1 ug Chromatin, 37 °C, 10 min | Cen-probeor | 94 (Cen-probe) | [ | ||
| Tandem Affinity Associated Strategy (TAAS) | 293T cells | 1% FH | 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, pH 8.0, 1% Triton X-100, 0.1% SDS, and freshly added protease inhibitors: 1 μg/mL aprotinin, 1 μg/mL leupeptin, 1 μg/mL pepstatin, 1 mM phenylmethylsulfonyl fluoride | Telomere | Sonication: Six times, 30 s on, | HA-FLAG-TIN2 | 92 | [ |
| Quantitative affinity purification-mass spectrometry (QAP-MS) | Drosophila Schneider S2 cell line | 15 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, 0.1% Triton X-100, 0 mM HEPES pH 7.6, Protease inhibitors | Centromere | MNase: 2000 U/109 cells, 20 min, 26 °C | Anti-GFP Affinity | 1871, | [ | |
| ChIP | Hela S3 cell line (5 × 109 cells) | 20 mM Hepes, pH 8.0, 15% ( | Centromere | Mnase: 6 U/mL Time = 30 min. | anti-CENP-A | 40 | [ | |
Figure 1Isolation of chromatin for proteome studies: Cells are fixed normally with formaldehyde to avoid the detachment of DNA interacting proteins during the isolation steps of chromatin. After fixation, cells are lysed (using Triton-100×/mechanical stress) to rupture outermost boundary (Cell wall/plasma membrane) that nuclei remain intake to prevent contamination of cytoplasmic proteins. After centrifugation and removal of cytoplasmic contents, nuclear membranes are lysed with SDS and formaldehyde-mediated fixed chromatin are released in the buffer for further processing.
Figure 2Capturing chromatin loci of interest using different baits: Chromatin are sheared into small fragments (100–300 bps) using either physical methods (i.e., sonication) or chemical method (i.e., Mnase enzyme). Chromatin specific fragments are captured using either protein baits (i.e., antibodies against DNA interacting proteins or against PTMs of interacting proteins) or nucleic acid probe (i.e., LNA, having specific sequence against DNA molecule present in chromatin fragments). Chromatin-bait complexes are precipitated using antibody binding beads (e.g., magnetic or streptavidin beads). Chromatin-antibody-protein beads complexes are washed and separated from non-specific unbound chromatin using magnetic field or appropriate column.
Figure 3Identification of proteins after elution and digestion of purified material: Chromatin proteins are normally eluted from chromatin complexes using glycine or 3× Laemeli method. Eluted proteins are further purified by acetone precipitation method or SDS-page to remove excessive salts and trypsin digested. Tryptic digested peptides are further processed for identification and quantification of proteins through MS/MS analysis.
Figure 4Chromatin associated proteome using different methodologies. Chromatin associated strategies are represented in circles, with arrow indicating the specific target location used for harvesting the sample material. Rectangle shaped represents novel proteins (NPs) and reported proteins (RPs) and protein previously reported but fail to be identified using these methodologies (FPRPs). Methodologies and their respective identified proteomics candidates are listed in same color. Abbreviation: Proteomics of isolated chromatin segments (PICh), tandem affinity associated strategy (TAAS), quantitative affinity purification-mass spectrometry (QAP-MS), chromatin immunoprecipitation (ChIP) (please see extended list in Abbreviations).